Sorrento Therapeutics (SRNE) stock forecast for 2022. Forecast tables and graphs.

Sorrento Therapeutics (SRNE) stock forecast for 2022

The forecast has been updated: September 13, 2021 17:55


Sorrento Therapeutics stock price online today

Analyst Target Price

26.67

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

1:25

Last Split Date

01.08.2013

Should you buy or sell Sorrento Therapeutics stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Sorrento Therapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $26.67 target price for Sorrento Therapeutics stock stock.

Today 200 Day Moving Average is the support level (8.46 $).

50 Day Moving Average is the support level (8.61 $).




SRNE Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 9.26 8.34 9.61 13.18 %
Feb 10.02 8.63 11.48 24.86 %
Mar 11.80 10.30 12.86 19.88 %
Apr 14.05 12.74 15.36 17.03 %
May 15.33 13.52 16.67 18.87 %
Jun 13.87 12.45 15.27 18.47 %
Jul 15.08 12.85 16.60 22.61 %
Aug 16.35 14.67 17.84 17.76 %
Sep 15.38 13.34 16.76 20.41 %
Oct 17.87 16.85 20.55 18.01 %
Nov 20.89 17.83 22.99 22.44 %
Dec 19.10 16.60 21.06 21.20 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Sorrento Therapeutics stock.


Sorrento Therapeutics overview

Sorrento Therapeutics Address

4955 DIRECTORS PLACE, SAN DIEGO, CA, US

Market Capitalization

2 360 952 000 $

EBITDA

-169 703 008

PE Ratio

None

PEG Ratio

-0.07

Dividend Per Share

None

Dividend Yield

0

EPS

-1.175

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.5

Trailing PE

0

Forward PE

4.771

EV To Revenue

47.31

EV To EBITDA

0

52 Week High

17.25

52 Week Low

6

50 Day Moving Average

8.61

200 Day Moving Average

8.46

Shares Outstanding

298100000

Shares Float

275173000

Shares Short Prior Month

46641300

Short Ratio

9.83

Percent Insiders

9.33

Percent Institutions

26.44

Sorrento Therapeutics stock forecast for this year


Sorrento Therapeutics stock forecast for Jan 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 9.26. Negative monthly dynamics of the instrument is expected with 13.179% volatility is expected.

Pessimistic forecast: 8.34

Optimistic: 9.61


Sorrento Therapeutics stock forecast for Feb 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 10.02. Positive monthly dynamics of the instrument is expected with 24.863% volatility is expected.

Pessimistic forecast: 8.63

Optimistic: 11.48


Sorrento Therapeutics stock forecast for Mar 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 11.80. Positive monthly dynamics of the instrument is expected with 19.884% volatility is expected.

Pessimistic forecast: 10.30

Optimistic: 12.86


Sorrento Therapeutics stock forecast for Apr 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 14.05. Positive monthly dynamics of the instrument is expected with 17.034% volatility is expected.

Pessimistic forecast: 12.74

Optimistic: 15.36


Sorrento Therapeutics stock forecast for May 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 15.33. Positive monthly dynamics of the instrument is expected with 18.870% volatility is expected.

Pessimistic forecast: 13.52

Optimistic: 16.67


Sorrento Therapeutics stock forecast for Jun 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 13.87. Negative monthly dynamics of the instrument is expected with 18.470% volatility is expected.

Pessimistic forecast: 12.45

Optimistic: 15.27


Sorrento Therapeutics stock forecast for Jul 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 15.08. Positive monthly dynamics of the instrument is expected with 22.613% volatility is expected.

Pessimistic forecast: 12.85

Optimistic: 16.60


Sorrento Therapeutics stock forecast for Aug 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 16.35. Positive monthly dynamics of the instrument is expected with 17.760% volatility is expected.

Pessimistic forecast: 14.67

Optimistic: 17.84


Sorrento Therapeutics stock forecast for Sep 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 15.38. Negative monthly dynamics of the instrument is expected with 20.407% volatility is expected.

Pessimistic forecast: 13.34

Optimistic: 16.76


Sorrento Therapeutics stock forecast for Oct 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 17.87. Positive monthly dynamics of the instrument is expected with 18.007% volatility is expected.

Pessimistic forecast: 16.85

Optimistic: 20.55


Sorrento Therapeutics stock forecast for Nov 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 20.89. Positive monthly dynamics of the instrument is expected with 22.440% volatility is expected.

Pessimistic forecast: 17.83

Optimistic: 22.99


Sorrento Therapeutics stock forecast for Dec 2022.
Estimated Average Forecasted Sorrento Therapeutics Price: 19.10. Negative monthly dynamics of the instrument is expected with 21.195% volatility is expected.

Pessimistic forecast: 16.60

Optimistic: 21.06



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.44 (16.09.2021) -0.04 %
AbbVie Inc.
ABBV 108.08 (16.09.2021) 0.29 %
Aeterna Zentaris Inc.
AEZS 0.6188 (15.09.2021) -3.12 %
Allakos Inc.
ALLK 108.23 (15.09.2021) 1.13 %
Allogene Therapeutics, Inc.
ALLO 25 (15.09.2021) 0.56 %
Amgen Inc.
AMGN 217.36 (16.09.2021) -0.35 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.9 (15.09.2021) 1.53 %
Aurora Cannabis Inc.
ACB 6.68 (15.09.2021) 2.77 %
Becton Dickinson and Company
BDX 261.68 (15.09.2021) 0.47 %
Biogen Inc.
BIIB 299.69 (16.09.2021) 0.16 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 135.99 (15.09.2021) 0.48 %
BioNTech SE
BNTX 372.65 (16.09.2021) 4.90 %
bluebird bio, Inc.
BLUE 17.8 (15.09.2021) 1.37 %
Boston Scientific Corp.
BSX 45.01 (15.09.2021) 0.36 %
Bristol-Myers Squibb Company
BMY 61.23 (16.09.2021) -1.24 %
Canopy Growth Corp.
CGC 14.79 (15.09.2021) 1.09 %
Castle Biosciences, Inc.
CSTL 76.21 (16.09.2021) 1.99 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 8.17 (15.09.2021) -1.57 %
Eli Lilly and Company
LLY 231.04 (16.09.2021) -1.15 %
Emergent BioSolutions Inc.
EBS 57.15 (15.09.2021) -0.16 %
Exelixis, Inc.
EXEL 20.54 (16.09.2021) 0.34 %
G1 Therapeutics, Inc.
GTHX 13.94 (15.09.2021) 0.50 %
Gilead Sciences, Inc.
GILD 71.76 (15.09.2021) 1.86 %
GlaxoSmithKline plc
GSK 39.22 (15.09.2021) -0.38 %
GoodRx Holdings, Inc.
GDRX 44.29 (15.09.2021) -0.72 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.04 (16.09.2021) 2.18 %
Inovio Pharmaceuticals, Inc.
INO 7.75 (16.09.2021) 2.38 %
Johnson & Johnson
JNJ 165.22 (16.09.2021) -0.12 %
Medtronic plc.
MDT 130.92 (16.09.2021) -0.55 %
Merck & Co., Inc.
MRK 71.97 (16.09.2021) -1.15 %
Moderna, Inc.
MRNA 434.46 (15.09.2021) 1.58 %
Novartis AG
NVS 85.08 (15.09.2021) -0.23 %
Novavax, Inc.
NVAX 232.3 (15.09.2021) -0.85 %
ObsEva SA
OBSV 3.06 (15.09.2021) 1.66 %
OrganiGram Holdings Inc.
OGI 2.4 (16.09.2021) -0.83 %
Pfizer Inc.
PFE 44.77 (15.09.2021) 0.13 %
Regeneron Pharmaceuticals, Inc.
REGN 653.18 (16.09.2021) 0.18 %
Sanofi
SNY 48.01 (15.09.2021) -0.56 %
Schrodinger, Inc.
SDGR 61.15 (16.09.2021) 0.30 %
Senseonics Holdings, Inc.
SENS 3.87 (15.09.2021) 2.65 %
Sorrento Therapeutics, Inc.
SRNE 7.94 (15.09.2021) 1.28 %
Stryker Corp.
SYK 277.1 (15.09.2021) 0.67 %
Sundial Growers Inc.
SNDL 0.7193 (16.09.2021) -1.44 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (16.09.2021) -0.22 %
Thermo Fisher Scientific Inc.
TMO 560.44 (16.09.2021) -0.45 %
Tilray, Inc.
TLRY 12.01 (16.09.2021) -0.17 %
UnitedHealth Group, Inc.
UNH 417.52 (15.09.2021) 1.21 %
Veeva Systems Inc.
VEEV 305 (16.09.2021) 1.75 %
Zomedica Corp.
ZOM 0.531 (15.09.2021) -2.25 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.32 (16.09.2021) -0.69 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.